only marginally significantP =0.074
Three of 20 (15.0%) GADAb-positive patients required insulin treatment compared to 24 of 442 (5.4%) GADAb-negative patients, a difference which was only marginally significant ( P =0.074).
Three of 20 (15.0%) GADAb-positive patients required insulin treatment compared to 24 of 442 (5.4%) GADAb-negative patients, a difference which was only marginally significant ( P =0.074).